These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27211205)

  • 21. Primary aldosteronism in general practice.
    Chan NN; Isaacs AJ
    Lancet; 1999 Mar; 353(9157):1013; author reply 1014. PubMed ID: 10459937
    [No Abstract]   [Full Text] [Related]  

  • 22. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
    Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
    Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].
    Waeber B; Feihl F
    Rev Med Suisse; 2012 Jan; 8(323):28-30. PubMed ID: 22303736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
    Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
    J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HYPERTENSION DUE TO RENAL ARTERY OCCLUSION SIMULATING PRIMARY ALDOSTERONISM.
    LAIDLAW JC; YENDT ER; BIRD CE; GORNALL AG
    Can Med Assoc J; 1964 Jan; 90(4):321-5. PubMed ID: 14111744
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clarification of a hypertension].
    Cottier P
    Schweiz Med Wochenschr; 1970 Sep; 100(37):1557-63. PubMed ID: 4324235
    [No Abstract]   [Full Text] [Related]  

  • 30. Laboratory challenges in primary aldosteronism screening and diagnosis.
    Rehan M; Raizman JE; Cavalier E; Don-Wauchope AC; Holmes DT
    Clin Biochem; 2015 Apr; 48(6):377-87. PubMed ID: 25619896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistant hypertension: who and how to evaluate.
    Acelajado MC; Calhoun DA
    Curr Opin Cardiol; 2009 Jul; 24(4):340-4. PubMed ID: 19395953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence.
    Börgel J; Springer S; Ghafoor J; Arndt D; Duchna HW; Barthel A; Werner S; Van Helden J; Hanefeld C; Neubauer H; Bulut D; Mügge A
    Clin Res Cardiol; 2010 Aug; 99(8):499-506. PubMed ID: 20361196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.
    Pratt-Ubunama MN; Nishizaka MK; Boedefeld RL; Cofield SS; Harding SM; Calhoun DA
    Chest; 2007 Feb; 131(2):453-9. PubMed ID: 17296647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single dose captopril as a diagnostic test for primary aldosteronism.
    Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
    J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary aldosteronism, a common entity? the myth persists.
    Padfield PL
    J Hum Hypertens; 2002 Mar; 16(3):159-62. PubMed ID: 11896504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An App for the Diagnosis of Primary Aldosteronism.
    Rossi GP; Bisogni V;
    Am J Hypertens; 2016 May; 29(5):660-1. PubMed ID: 27009784
    [No Abstract]   [Full Text] [Related]  

  • 40. 'Captopril test', with blood pressure and peripheral renin as response variables in hypertensive patients with suspected renal artery stenosis.
    Schreij G; van Es PN; Schiffers PM; Lavrijssen AT; de Leeuw PW
    J Hum Hypertens; 1995 Sep; 9(9):741-6. PubMed ID: 8551488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.